10-K Filing

ELI LILLY & CO CIK: 59478 FY 2021

Filing Information

Form Type	10-K
Accession Number	`0000059478-22-000068`
Period End Date	20211231
Filing Date	20220223
Fiscal Year	2021
Fiscal Period	FY
XBRL Instance	lly-20211231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 63 Cash Flow Statement 117 Stockholders Equity 13 Comprehensive Income 27

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$25.90M	USD	Point-in-time
Accounts receivable, allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$22.50M	USD	Point-in-time
Authorized (in shares)	`CommonStockSharesAuthorized`	3.20M	shares	Point-in-time
Authorized (in shares)	`CommonStockSharesAuthorized`	3.20M	shares	Point-in-time
Cash and cash equivalents (Note 7)	`CashAndCashEquivalentsAtCarryingValue`	$3.82B	USD	Point-in-time
Cash and cash equivalents (Note 7)	`CashAndCashEquivalentsAtCarryingValue`	$3.66B	USD	Point-in-time
Issued (in shares)	`CommonStockSharesIssued`	954,116.00	shares	Point-in-time
Issued (in shares)	`CommonStockSharesIssued`	957,077.00	shares	Point-in-time
Short-term investments (Note 7)	`ShortTermInvestments`	$90.10M	USD	Point-in-time
Short-term investments (Note 7)	`ShortTermInvestments`	$24.20M	USD	Point-in-time
Accounts receivable, net of allowances of $22.5 (2021) and $25.9 (2020)	`AccountsReceivableNetCurrent`	$6.67B	USD	Point-in-time
Accounts receivable, net of allowances of $22.5 (2021) and $25.9 (2020)	`AccountsReceivableNetCurrent`	$5.88B	USD	Point-in-time
Other receivables	`OtherReceivables`	$1.45B	USD	Point-in-time
Other receivables	`OtherReceivables`	$1.05B	USD	Point-in-time
Inventories (Note 6)	`InventoryNet`	$3.98B	USD	Point-in-time
Inventories (Note 6)	`InventoryNet`	$3.89B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseCurrent`	$2.87B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseCurrent`	$2.53B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.46B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$18.45B	USD	Point-in-time
Investments (Note 7)	`LongTermInvestments`	$3.21B	USD	Point-in-time
Investments (Note 7)	`LongTermInvestments`	$2.97B	USD	Point-in-time
Goodwill (Note 8)	`Goodwill`	$3.77B	USD	Point-in-time
Goodwill (Note 8)	`Goodwill`	$3.89B	USD	Point-in-time
Other intangibles, net (Note 8)	`IntangibleAssetsNetExcludingGoodwill`	$7.45B	USD	Point-in-time
Other intangibles, net (Note 8)	`IntangibleAssetsNetExcludingGoodwill`	$7.69B	USD	Point-in-time
Deferred tax assets (Note 14)	`DeferredIncomeTaxAssetsNet`	$2.49B	USD	Point-in-time
Deferred tax assets (Note 14)	`DeferredIncomeTaxAssetsNet`	$2.83B	USD	Point-in-time
Property and equipment, net (Note 9)	`PropertyPlantAndEquipmentNet`	$8.99B	USD	Point-in-time
Property and equipment, net (Note 9)	`PropertyPlantAndEquipmentNet`	$8.68B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsMiscellaneousNoncurrent`	$4.08B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsMiscellaneousNoncurrent`	$3.48B	USD	Point-in-time
Total assets	`Assets`	$48.81B	USD	Point-in-time
Total assets	`Assets`	$46.63B	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt (Note 11)	`DebtCurrent`	$8.70M	USD	Point-in-time
Short-term borrowings and current maturities of long-term debt (Note 11)	`DebtCurrent`	$1.54B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.67B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.61B	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$958.10M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$997.20M	USD	Point-in-time
Sales rebates and discounts	`SalesRebatesAndDiscounts`	$6.85B	USD	Point-in-time
Sales rebates and discounts	`SalesRebatesAndDiscounts`	$5.85B	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$885.50M	USD	Point-in-time
Dividends payable	`DividendsPayableCurrent`	$770.60M	USD	Point-in-time
Income taxes payable (Note 14)	`TaxesPayableCurrent`	$126.90M	USD	Point-in-time
Income taxes payable (Note 14)	`TaxesPayableCurrent`	$495.10M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$2.75B	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$3.03B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.05B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.48B	USD	Point-in-time
Long-term debt (Note 11)	`LongTermDebtNoncurrent`	$16.59B	USD	Point-in-time
Long-term debt (Note 11)	`LongTermDebtNoncurrent`	$15.35B	USD	Point-in-time
Accrued retirement benefits (Note 15)	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$4.09B	USD	Point-in-time
Accrued retirement benefits (Note 15)	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$1.95B	USD	Point-in-time
Long-term income taxes payable (Note 14)	`AccruedIncomeTaxesNoncurrent`	$3.92B	USD	Point-in-time
Long-term income taxes payable (Note 14)	`AccruedIncomeTaxesNoncurrent`	$3.84B	USD	Point-in-time
Deferred tax liabilities (Note 14)	`DeferredIncomeTaxLiabilitiesNet`	$1.73B	USD	Point-in-time
Deferred tax liabilities (Note 14)	`DeferredIncomeTaxLiabilitiesNet`	$2.10B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$1.64B	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$1.71B	USD	Point-in-time
Total other liabilities	`LiabilitiesNoncurrent`	$28.33B	USD	Point-in-time
Total other liabilities	`LiabilitiesNoncurrent`	$24.60B	USD	Point-in-time
Commitments and Contingencies (Note 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 16)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stockno par value Authorized shares: 3,200,000 Issued shares: 954,116 (2021) and 957,077 (2020)	`CommonStockValue`	$598.20M	USD	Point-in-time
Common stockno par value Authorized shares: 3,200,000 Issued shares: 954,116 (2021) and 957,077 (2020)	`CommonStockValue`	$596.30M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$6.83B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$6.78B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$7.83B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$8.96B	USD	Point-in-time
Employee benefit trust	`CommonStockSharesHeldInEmployeeTrust`	$3.01B	USD	Point-in-time
Employee benefit trust	`CommonStockSharesHeldInEmployeeTrust`	$3.01B	USD	Point-in-time
Accumulated other comprehensive loss (Note 17)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-4.34B	USD	Point-in-time
Accumulated other comprehensive loss (Note 17)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-6.50B	USD	Point-in-time
Cost of common stock in treasury	`TreasuryStockValue`	$55.70M	USD	Point-in-time
Cost of common stock in treasury	`TreasuryStockValue`	$52.70M	USD	Point-in-time
Total Eli Lilly and Company shareholders' equity	`StockholdersEquity`	$8.98B	USD	Point-in-time
Total Eli Lilly and Company shareholders' equity	`StockholdersEquity`	$5.64B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$175.60M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$183.60M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.83B	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.15B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$48.81B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$46.63B	USD	Point-in-time

Income Statement 63 line items

Line Item	Tag	Value	Unit	Period
Revenue (Note 2)	`Revenues`	$24.54B	USD	Annual
Revenue (Note 2)	`Revenues`	$22.32B	USD	Annual
Revenue (Note 2)	`Revenues`	$28.32B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$4.72B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$7.31B	USD	Annual
Cost of sales	`CostOfGoodsAndServicesSold`	$5.48B	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$7.03B	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$5.59B	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$6.09B	USD	Annual
Marketing, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$6.21B	USD	Annual
Marketing, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$6.12B	USD	Annual
Marketing, selling, and administrative	`SellingGeneralAndAdministrativeExpense`	$6.43B	USD	Annual
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$660.40M	USD	Annual
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$874.90M	USD	Annual
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$239.60M	USD	Annual
Asset impairment, restructuring, and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	$316.10M	USD	Annual
Asset impairment, restructuring, and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	$575.60M	USD	Annual
Asset impairment, restructuring, and other special charges (Note 5)	`RestructuringSettlementAndImpairmentProvisions`	$131.20M	USD	Annual
Othernet, (income) expense (Note 18)	`NonoperatingIncomeExpense`	$291.60M	USD	Annual
Othernet, (income) expense (Note 18)	`NonoperatingIncomeExpense`	$1.17B	USD	Annual
Othernet, (income) expense (Note 18)	`NonoperatingIncomeExpense`	$-201.60M	USD	Annual
Costs, expenses, and other	`CostOfSalesOperatingExpensesAndOtherNet`	$22.16B	USD	Annual
Costs, expenses, and other	`CostOfSalesOperatingExpensesAndOtherNet`	$17.05B	USD	Annual
Costs, expenses, and other	`CostOfSalesOperatingExpensesAndOtherNet`	$17.31B	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$5.27B	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$7.23B	USD	Annual
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$6.16B	USD	Annual
Income taxes (Note 14)	`IncomeTaxExpenseBenefit`	$573.80M	USD	Annual
Income taxes (Note 14)	`IncomeTaxExpenseBenefit`	$1.04B	USD	Annual
Income taxes (Note 14)	`IncomeTaxExpenseBenefit`	$628.00M	USD	Annual
Net income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$4.64B	USD	Annual
Net income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$6.19B	USD	Annual
Net income from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$5.58B	USD	Annual
Net income from discontinued operations (Note 19)	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	Annual
Net income from discontinued operations (Note 19)	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$3.68B	USD	Annual
Net income from discontinued operations (Note 19)	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	Annual
Net income	`NetIncomeLoss`	$5.58B	USD	Annual
Net income	`NetIncomeLoss`	$8.32B	USD	Annual
Net income	`NetIncomeLoss`	$6.19B	USD	Annual
Earnings from continuing operations - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$6.82	USD	Annual
Earnings from continuing operations - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$6.15	USD	Annual
Earnings from continuing operations - basic (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$4.98	USD	Annual
Earnings from discontinued operations - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	$3.95	USD	Annual
Earnings from discontinued operations - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	Annual
Earnings from discontinued operations - basic (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare`	-	USD	Annual
Earnings per share - basic (in usd per share)	`EarningsPerShareBasic`	$6.15	USD	Annual
Earnings per share - basic (in usd per share)	`EarningsPerShareBasic`	$8.93	USD	Annual
Earnings per share - basic (in usd per share)	`EarningsPerShareBasic`	$6.82	USD	Annual
Earnings from continuing operations - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$6.79	USD	Annual
Earnings from continuing operations - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$4.96	USD	Annual
Earnings from continuing operations - diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$6.12	USD	Annual
Earnings from discontinued operations - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	Annual
Earnings from discontinued operations - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	$3.93	USD	Annual
Earnings from discontinued operations - diluted (in usd per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare`	-	USD	Annual
Earnings per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$6.12	USD	Annual
Earnings per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$8.89	USD	Annual
Earnings per share - diluted (in usd per share)	`EarningsPerShareDiluted`	$6.79	USD	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	931.06M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	907.63M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	906.96M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	935.68M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	912.50M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	911.68M	shares	Annual

Cash Flow Statement 117 line items

Line Item	Tag	Value	Unit	Period
Discontinued operations cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations`	$677.50M	USD	Point-in-time
Net income	`NetIncomeLoss`	$5.58B	USD	Annual
Net income	`NetIncomeLoss`	$8.32B	USD	Annual
Net income	`NetIncomeLoss`	$6.19B	USD	Annual
Gain related to disposition of Elanco (Note 19)	`GainLossOnSaleOfBusiness`	$3.68B	USD	Annual
Gain related to disposition of Elanco (Note 19)	`GainLossOnSaleOfBusiness`	-	USD	Annual
Gain related to disposition of Elanco (Note 19)	`GainLossOnSaleOfBusiness`	-	USD	Annual
Gain on sale of antibiotic business in China (Note 3)	`DisposalGroupNotDiscontinuedOperationGainLossOnDisposal`	-	USD	Annual
Gain on sale of antibiotic business in China (Note 3)	`DisposalGroupNotDiscontinuedOperationGainLossOnDisposal`	$309.80M	USD	Annual
Gain on sale of antibiotic business in China (Note 3)	`DisposalGroupNotDiscontinuedOperationGainLossOnDisposal`	-	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.23B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.55B	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.32B	USD	Annual
Debt extinguishment loss (Note 11)	`GainsLossesOnExtinguishmentOfDebt`	$-252.50M	USD	Annual
Debt extinguishment loss (Note 11)	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Debt extinguishment loss (Note 11)	`GainsLossesOnExtinguishmentOfDebt`	$-405.20M	USD	Annual
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$802.30M	USD	Annual
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-62.40M	USD	Annual
Change in deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$134.50M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$308.10M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$342.80M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$312.40M	USD	Annual
Net investment gains	`GainLossOnInvestments`	$403.10M	USD	Annual
Net investment gains	`GainLossOnInvestments`	$178.00M	USD	Annual
Net investment gains	`GainLossOnInvestments`	$1.44B	USD	Annual
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$660.40M	USD	Annual
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$874.90M	USD	Annual
Acquired in-process research and development (Note 3)	`AcquiredInProcessResearchAndDevelopment`	$239.60M	USD	Annual
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$511.40M	USD	Annual
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$333.90M	USD	Annual
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$499.30M	USD	Annual
Receivables(increase) decrease	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.35B	USD	Annual
Receivables(increase) decrease	`IncreaseDecreaseInAccountsAndOtherReceivables`	$1.28B	USD	Annual
Receivables(increase) decrease	`IncreaseDecreaseInAccountsAndOtherReceivables`	$127.20M	USD	Annual
Inventories(increase) decrease	`IncreaseDecreaseInInventories`	$258.70M	USD	Annual
Inventories(increase) decrease	`IncreaseDecreaseInInventories`	$235.90M	USD	Annual
Inventories(increase) decrease	`IncreaseDecreaseInInventories`	$533.40M	USD	Annual
Other assets(increase) decrease	`IncreaseDecreaseInOtherOperatingAssets`	$602.30M	USD	Annual
Other assets(increase) decrease	`IncreaseDecreaseInOtherOperatingAssets`	$457.10M	USD	Annual
Other assets(increase) decrease	`IncreaseDecreaseInOtherOperatingAssets`	$-1.52B	USD	Annual
Income taxes payableincrease (decrease)	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-359.70M	USD	Annual
Income taxes payableincrease (decrease)	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$322.00M	USD	Annual
Income taxes payableincrease (decrease)	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-221.30M	USD	Annual
Accounts payable and other liabilitiesincrease (decrease)	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-664.10M	USD	Annual
Accounts payable and other liabilitiesincrease (decrease)	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.27B	USD	Annual
Accounts payable and other liabilitiesincrease (decrease)	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-477.70M	USD	Annual
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$4.84B	USD	Annual
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$6.50B	USD	Annual
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$7.26B	USD	Annual
Purchases of property and equipment	`PaymentsToAcquireOtherPropertyPlantAndEquipment`	$1.39B	USD	Annual
Purchases of property and equipment	`PaymentsToAcquireOtherPropertyPlantAndEquipment`	$1.03B	USD	Annual
Purchases of property and equipment	`PaymentsToAcquireOtherPropertyPlantAndEquipment`	$1.31B	USD	Annual
Proceeds from sales and maturities of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$136.60M	USD	Annual
Proceeds from sales and maturities of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$129.70M	USD	Annual
Proceeds from sales and maturities of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$47.40M	USD	Annual
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$83.50M	USD	Annual
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$42.70M	USD	Annual
Purchases of short-term investments	`PaymentsToAcquireShortTermInvestments`	$11.40M	USD	Annual
Proceeds from sales of noncurrent investments	`ProceedsFromSaleAndMaturityOfOtherInvestments`	$800.00M	USD	Annual
Proceeds from sales of noncurrent investments	`ProceedsFromSaleAndMaturityOfOtherInvestments`	$757.10M	USD	Annual
Proceeds from sales of noncurrent investments	`ProceedsFromSaleAndMaturityOfOtherInvestments`	$609.80M	USD	Annual
Purchases of noncurrent investments	`PaymentsToAcquireOtherInvestments`	$358.70M	USD	Annual
Purchases of noncurrent investments	`PaymentsToAcquireOtherInvestments`	$247.50M	USD	Annual
Purchases of noncurrent investments	`PaymentsToAcquireOtherInvestments`	$929.90M	USD	Annual
Purchases of in-process research and development	`PurchasedInProcessResearchAndDevelopment`	$641.20M	USD	Annual
Purchases of in-process research and development	`PurchasedInProcessResearchAndDevelopment`	$563.40M	USD	Annual
Purchases of in-process research and development	`PurchasedInProcessResearchAndDevelopment`	$319.60M	USD	Annual
Cash paid for acquisitions, net of cash acquired (Note 3)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$747.40M	USD	Annual
Cash paid for acquisitions, net of cash acquired (Note 3)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$6.92B	USD	Annual
Cash paid for acquisitions, net of cash acquired (Note 3)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$849.30M	USD	Annual
Cash distributed to Elanco upon disposition	`CashDivestedFromDeconsolidation`	-	USD	Annual
Cash distributed to Elanco upon disposition	`CashDivestedFromDeconsolidation`	-	USD	Annual
Cash distributed to Elanco upon disposition	`CashDivestedFromDeconsolidation`	$374.00M	USD	Annual
Cash received for sale of antibiotic business in China	`ProceedsFromDivestitureOfBusinesses`	-	USD	Annual
Cash received for sale of antibiotic business in China	`ProceedsFromDivestitureOfBusinesses`	-	USD	Annual
Cash received for sale of antibiotic business in China	`ProceedsFromDivestitureOfBusinesses`	$354.80M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-102.80M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$248.70M	USD	Annual
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-24.30M	USD	Annual
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.76B	USD	Annual
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.26B	USD	Annual
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-8.08B	USD	Annual
Dividends paid	`PaymentsOfDividends`	$2.69B	USD	Annual
Dividends paid	`PaymentsOfDividends`	$2.41B	USD	Annual
Dividends paid	`PaymentsOfDividends`	$3.09B	USD	Annual
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$-4.00M	USD	Annual
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$995.40M	USD	Annual
Net change in short-term borrowings	`ProceedsFromRepaymentsOfShortTermDebt`	$-1.49B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$6.56B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$2.41B	USD	Annual
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$2.06B	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$276.50M	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$2.87B	USD	Annual
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.91B	USD	Annual
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$4.40B	USD	Annual
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$1.25B	USD	Annual
Purchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$500.00M	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-200.10M	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-295.90M	USD	Annual
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-241.60M	USD	Annual
Net Cash Used for Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.14B	USD	Annual
Net Cash Used for Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-4.13B	USD	Annual
Net Cash Used for Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-2.32B	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-205.70M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$216.00M	USD	Annual
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$-89.90M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.32B	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$161.40M	USD	Annual
Net increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-5.66B	USD	Annual
Cash and cash equivalents at beginning of year (2019 includes $677.5 of discontinued operations)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.82B	USD	Point-in-time
Cash and cash equivalents at beginning of year (2019 includes $677.5 of discontinued operations)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.66B	USD	Point-in-time
Cash and cash equivalents at beginning of year (2019 includes $677.5 of discontinued operations)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.34B	USD	Point-in-time
Cash and cash equivalents at beginning of year (2019 includes $677.5 of discontinued operations)	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$8.00B	USD	Point-in-time
Cash and Cash Equivalents at End of Year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.82B	USD	Point-in-time
Cash and Cash Equivalents at End of Year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.66B	USD	Point-in-time
Cash and Cash Equivalents at End of Year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.34B	USD	Point-in-time
Cash and Cash Equivalents at End of Year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$8.00B	USD	Point-in-time

Stockholders Equity 13 line items

Line Item	Tag	Value	Unit	Period
Cash dividend declared per share (in usd per share)	`CommonStockDividendsPerShareDeclared`	$3.07	USD	Annual
Cash dividend declared per share (in usd per share)	`CommonStockDividendsPerShareDeclared`	$3.53	USD	Annual
Cash dividend declared per share (in usd per share)	`CommonStockDividendsPerShareDeclared`	$2.68	USD	Annual
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.83B	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.15B	USD	Point-in-time
Purchase of treasury shares	`TreasuryStockValueAcquiredCostMethod`	$250.00M	USD	3 Qtrs
Purchase of treasury shares	`TreasuryStockValueAcquiredCostMethod`	$500.00M	USD	Annual
Purchase of treasury shares	`TreasuryStockValueAcquiredCostMethod`	$4.40B	USD	Annual
Purchase of treasury shares	`TreasuryStockValueAcquiredCostMethod`	$1.00B	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredCostMethod`	$1.25B	USD	Annual
Deconsolidation of Elanco	`ImpactonEquityofSaleofNoncontrollingInterestinSubsidiary`	$-1.03B	USD	Annual
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$5.83B	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.15B	USD	Point-in-time

Comprehensive Income 27 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$5.58B	USD	Annual
Net income	`NetIncomeLoss`	$8.32B	USD	Annual
Net income	`NetIncomeLoss`	$6.19B	USD	Annual
Change in foreign currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$13.50M	USD	Annual
Change in foreign currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$-89.90M	USD	Annual
Change in foreign currency translation gains (losses)	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax`	$122.10M	USD	Annual
Change in net unrealized gains (losses) on securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$34.40M	USD	Annual
Change in net unrealized gains (losses) on securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$-15.90M	USD	Annual
Change in net unrealized gains (losses) on securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax`	$14.20M	USD	Annual
Change in defined benefit pension and retiree health benefit plans (Note 15)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax`	$970.00M	USD	Annual
Change in defined benefit pension and retiree health benefit plans (Note 15)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax`	$-2.70B	USD	Annual
Change in defined benefit pension and retiree health benefit plans (Note 15)	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax`	$157.10M	USD	Annual
Change in effective portion of cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$-152.90M	USD	Annual
Change in effective portion of cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$34.30M	USD	Annual
Change in effective portion of cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax`	$151.60M	USD	Annual
Other comprehensive income (loss) from continuing operations before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$-991.20M	USD	Annual
Other comprehensive income (loss) from continuing operations before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$2.85B	USD	Annual
Other comprehensive income (loss) from continuing operations before income taxes	`OtherComprehensiveIncomeLossBeforeTax`	$-173.70M	USD	Annual
Benefit (provision) for income taxes related to other comprehensive income (loss) from continuing operations	`OtherComprehensiveIncomeLossTax`	$-151.00M	USD	Annual
Benefit (provision) for income taxes related to other comprehensive income (loss) from continuing operations	`OtherComprehensiveIncomeLossTax`	$-200.90M	USD	Annual
Benefit (provision) for income taxes related to other comprehensive income (loss) from continuing operations	`OtherComprehensiveIncomeLossTax`	$695.30M	USD	Annual
Net other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$27.20M	USD	Annual
Net other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-783.40M	USD	Annual
Net other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$2.15B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.74B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$6.22B	USD	Annual
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$7.54B	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.